Rosenblatt cuts Calix target, sees ‘strong buying opportunity’

Rosenblatt analyst Mike Genovese lowered the firm’s price target on Calix (CALX) to $70 from $85 and keeps a Buy rating on the shares. The firm says the selloff in shares from Calix’s “smaller than normal” quarterly beat as a buying opportunity. It sees a “strong buying opportunity in front of several catalysts” in 2026.